Location History:
- Duarte, CA (US) (2011 - 2018)
- Monrovia, CA (US) (2015 - 2021)
Company Filing History:
12 out of 639 
2 out of 1,187 
Years Active: 2011-2025
Title: Innovations in Cancer Treatment by Inventor Jiehua Zhou
Introduction
Jiehua Zhou, an innovative inventor based in Monrovia, CA, has significantly contributed to the field of biomedicine with his extensive portfolio of 12 patents. His work primarily focuses on targeted therapies that have the potential to transform the treatment of cancer.
Latest Patents
Among his latest inventions are the CCR7 aptamers, which specifically bind to and internalize into CCR7-expressing cells. These aptamers have been disclosed as therapeutic agents, either on their own or in combination with small molecules, forming conjugates that enhance targeted delivery. The methods outlined in these patents provide novel ways to treat subjects suffering from cancer by administering an effective amount of either the aptamer or the aptamer-small molecule conjugate.
Career Highlights
Jiehua Zhou has demonstrated remarkable expertise throughout his career. He has worked for esteemed organizations such as City of Hope and The Scripps Research Institute, where he applied his innovative knowledge in cancer research. His commitment to advancing medical technology is evident through the patents he has filed.
Collaborations
In his professional journey, Zhou has collaborated with notable colleagues like John J. Rossi and Katrin Tiemann. These partnerships have likely enriched his research experience and contributed to the successful development of his patented inventions.
Conclusion
With 12 patents to his name, Jiehua Zhou is making strides in the healthcare sector, particularly in cancer therapy. His work with CCR7 aptamers highlights the importance of innovation in the treatment of complex diseases. As the medical field advances, Zhou's inventions may play a crucial role in enhancing patient care and developing more effective therapeutic strategies.